Countries among the hardest hit by the coronavirus unveiled further control measures Friday to battle rising cases, hitting summer tourism and aspects of everyday life around the globe.
Aug 14, 2020
0
5
It took less than a week for the Trump administration to kill the considerable buzz created Jan. 1 when California's broad marijuana legalization law took effect, creating the largest legal U.S. cannabis marketplace .
Dec 27, 2018
0
0
When Canada legalized recreational marijuana in October, it emerged as the world leader in the industry—and U.S. companies are scrambling to get in on the action. Uruguay may have been the first country to legalize pot, ...
Dec 7, 2018
0
1
Eli Lilly is planning an initial public offering for part of an animal health business that brought in about 13 percent of all company revenue last year.
Jul 24, 2018
0
3
Shares of Axovant Sciences nearly doubled in value after the dementia drug developer said its initial public offering raised $315 million, more than Axovant had expected.
Jun 11, 2015
0
11
Shares of cancer drug developer Adaptimmune fell Wednesday after the British company's initial public offering raised $191.3 million.
May 6, 2015
0
4
British-based drugmaker GlaxoSmithKline opted Wednesday to keep its stake in its stand-alone HIV business as it set out its strategy following a big deal with Switzerland's Novartis.
May 6, 2015
0
5
Shares of Adamas Pharmaceuticals rose Thursday after the drug developer's initial public offering raised $48 million.
Apr 10, 2014
0
0
The conservative government of Prime Minister Tony Abbott on Wednesday said it would press ahead with the sale of Australia's largest health insurer Medibank Private via an initial public offering.
Mar 26, 2014
0
0
British drugmaker AstraZeneca PLC plans to spend about $260 million on Omthera Pharmaceuticals Inc., a specialty drug developer with only 14 employees but has a potential treatment for patients who have high levels of fats ...
May 28, 2013
0
0
